Zivo Bioscience, Inc. (ZIVO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ZIVO
See up to 3 months of ZIVO. The 7-day demo opens the 1M and 3M ranges and puts ZIVO on your watchlist.
Start 7-day demoLatest ZIVO insider trades
Mark E. Strome - 10% OwnerOpen-market purchase$200K- Laith L. YaldooOpen-market purchase
About Zivo Bioscience, Inc. (ZIVO)
The SEC lists Zivo Bioscience, Inc. under CIK 0001101026, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
ZIVO Form 4 activity by transaction type, last 90 days
No Form 4 activity for ZIVO in the last 90 days.
ZIVO insider transactions (Form 4)
2720 Form 4 filings on record, the earliest from Oct 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock | 100,000 footnote F1 | $2.00 | $200K | |
| ||||||
| Laith L. Yaldoo | Open-market purchase | Common Stock | 1,543 | $9.72 | $15K | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock | 20,000 footnote F1 | $9.77 | $195K | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock Purchase Warrant | 2,000 footnote F1 | $0.00 | - | |
| ||||||
| Laith L. Yaldoo | Open-market purchase | Common Stock | 2,434 | $10.27 | $25K | |
| Alison A. Cornell | Open-market purchase | Common Stock | 11,709 | $8.54 | $100K | |
| John Bernard Payne - Officer | Open-market purchase | Common Stock | 11,709 | $8.54 | $100K | |
| Laith L. Yaldoo - Director | Open-market purchase | Common Stock | 2,777 | $9.00 | $25K | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock Purchase Warrant | 2,025 | $0.00 | - | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock | 20,259 footnote F1 | $12.34 | $250K | |
| ||||||
| Laith L. Yaldoo | Open-market purchase | Common Stock | 1,659 | $12.05 | $20K | |
| Christopher D. Maggiore | Open-market purchase | Common Stock | 23,682 | $12.01 | $284K | |
| Laith L. Yaldoo - Director | Open-market purchase | Common Stock | 15,322 | $15.99 | $245K | |
| Laith L. Yaldoo | Grant or award | Nonstatutory Stock Options to buy Common Stock | 926 | $10.20 footnote F1 | $9K | |
| ||||||
| Christopher D. Maggiore | Grant or award | Nonstatutory Stock Options to buy Common Stock | 1,075 | $10.20 footnote F1 | $11K | |
| ||||||
| Alison A. Cornell | Grant or award | Nonstatutory Stock Options to buy Common Stock | 1,223 | $10.20 footnote F1 | $12K | |
| ||||||
| Laith L. Yaldoo | Open-market purchase | Common Stock | 3,488 | $14.33 | $50K | |
| Laith L. Yaldoo | Open-market purchase | Warrant for Common Stock | 348 | $14.33 | $5K | |
| Christopher D. Maggiore | Open-market sale | Common Stock | 20 | $16.25 | $325 | |
| Laith L. Yaldoo | Open-market purchase | Common Stock | 7,200 | $17.53 | $126K | |
| Laith L. Yaldoo | Open-market purchase | Common Stock | 2,880 | $17.53 | $50K | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock | 75,000 | $20.19 | $1.51M | |
| Mark E. Strome - 10% Owner | Open-market purchase | Common Stock Purchase Warrant | 7,500 | $0.00 | - | |
| Laith L. Yaldoo - Director | Open-market purchase | Common Stock | 3,133 | $15.96 | $50K | |
| Laith L. Yaldoo - Director | Open-market purchase | Warrant to Purchase Common Stock | 313 | $15.96 | $5K | |
| John Bernard Payne - Officer | Open-market purchase | Common Stock | 6,343 | $15.76 | $100K | |
| John Bernard Payne - Officer | Open-market purchase | Common Stock Warrant | 634 | $15.77 | $10K | |
Item 5.02, 7.01, 9.01
ZIVO insider trading FAQ
What is the latest insider trade for ZIVO?
Zivo Bioscience, Inc. (ZIVO) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-24. The full record for ZIVO runs to 20 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ZIVO stock?
No insider purchases of ZIVO were filed in the last 90 days. 23 purchases are on record for this company.
How many insiders are selling ZIVO stock?
No insider sales of ZIVO were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ZIVO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ZIVO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark E. Strome view on EDGAR
- - Laith L. Yaldoo view on EDGAR
- - Mark E. Strome view on EDGAR
- - Laith L. Yaldoo view on EDGAR
- - Alison A. Cornell view on EDGAR
- - John Bernard Payne view on EDGAR
- - Laith L. Yaldoo view on EDGAR
- - Mark E. Strome view on EDGAR
- - Laith L. Yaldoo view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ZIVO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ZIVO with a 7-day demo
- ZIVO on your watchlist
- Every ZIVO Form 4 filing on record
- Up to 3 months of ZIVO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
